Management
Michael Kleine, President & CEO He holds a BA in Biology and Math from Missouri Valley College and a MA in Marketing from Webster University. |
Ken Ludlum, Chief Financial Officer From 1995-2000 he was Chief Financial Officer at Perclose (NASD:PERC), an interventional cardiology products company. During his five years at Perclose, sales grew from $2 million to $100 million a year, when Abbott Laboratories purchased Perclose. Prior to that, he was in investment banking for 10 years, primarily at Montgomery Securities, working with emerging growth health care companies. He holds a BS degree from Lehigh University and a MBA from Columbia Business School. Richard Romley, Senior Vice President, Research & Development Prior to joining EGS, Mr. Romley was Director of Research and Development and Chairman of the Patent Review Board for Boston Scientific Corporation’s imaging franchise. Prior to Boston Scientific, Mr. Romley held a number of leadership positions including Vice President of Technology & Operations at BioInterventional Corporation and project management positions at Prolifix, Heartport, and Baxter Healthcare Corporation. Mr. Romley holds several patents and a BS in Mechanical Engineering from San Diego State University. Randall Sullivan, Senior Vice President, Operations His previous experience also includes leading the manufacturing and supply chain operations for Sanarus Medical, Microvention, and Cardiac Pathways. His long career also includes leadership roles in larger medical device companies such as Boston Scientific and Mallinckrodt/Covidien. Mr. Sullivan has a Bachelors Degree in Electrical Engineering from California State University, Fullerton. David Schummers, Vice President, Marketing Mr. Schummers joined Medtronic through the 2007 acquisition of Kyphon Inc. While at Kyphon, Mr. Schummers served in key leadership roles in marketing, R&D, operations and finance. Prior to joining Kyphon, Mr. Schummers headed the life science practice of the investor relations consulting firm the Blueshirt Group, worked in equity research at Piper Jaffray and contributed as a business writer to the medical device trade journal The Gray Sheet. Mr. Schummers holds a BA in Economics from Oberlin College. Greg Bowles, Vice President, Sales Mr. Bowles holds a BA in Business Administration from Northwood University in Midland, Michigan. Michael Daniel, Vice President, Regulatory Affairs Prior to joining EndoGastric Solutions, Mr. Daniel was President of a medical device consulting firm where helped venture capital funded companies bring products to market through the effective management of clinical studies and regulatory processes. He has familiarity with a broad range of medical devices, including: implantable heart assist devices (Novacor), in vitro diagnostics (SKD), endometrial resection/ablation devices (FemRx), coronary and peripheral catheters (LuMend, FHT, Kerberos), coronary anastomotic and general surgical implantable clips (Coalescent), implantable bronchial valves (Emphasis) and endoscopic/percutaneous robotics (Intuitive Surgical, Hansen Medical, NeoGuide). Mr. Daniel holds a BS in microbiology from Michigan State University, a MS in biology from the Illinois Institute of Technology, and a MBA from University of California, Berkeley. |
|
NP01936-01A


